Cargando…

Point‐of‐care oral cytology tool for the screening and assessment of potentially malignant oral lesions

BACKGROUND: The effective detection and monitoring of potentially malignant oral lesions (PMOL) are critical to identifying early‐stage cancer and improving outcomes. In the current study, the authors described cytopathology tools, including machine learning algorithms, clinical algorithms, and test...

Descripción completa

Detalles Bibliográficos
Autores principales: McRae, Michael P., Modak, Sayli S., Simmons, Glennon W., Trochesset, Denise A., Kerr, A. Ross, Thornhill, Martin H., Redding, Spencer W., Vigneswaran, Nadarajah, Kang, Stella K., Christodoulides, Nicolaos J., Murdoch, Craig, Dietl, Steven J., Markham, Roger, McDevitt, John T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078980/
https://www.ncbi.nlm.nih.gov/pubmed/32032477
http://dx.doi.org/10.1002/cncy.22236
_version_ 1783507732321533952
author McRae, Michael P.
Modak, Sayli S.
Simmons, Glennon W.
Trochesset, Denise A.
Kerr, A. Ross
Thornhill, Martin H.
Redding, Spencer W.
Vigneswaran, Nadarajah
Kang, Stella K.
Christodoulides, Nicolaos J.
Murdoch, Craig
Dietl, Steven J.
Markham, Roger
McDevitt, John T.
author_facet McRae, Michael P.
Modak, Sayli S.
Simmons, Glennon W.
Trochesset, Denise A.
Kerr, A. Ross
Thornhill, Martin H.
Redding, Spencer W.
Vigneswaran, Nadarajah
Kang, Stella K.
Christodoulides, Nicolaos J.
Murdoch, Craig
Dietl, Steven J.
Markham, Roger
McDevitt, John T.
author_sort McRae, Michael P.
collection PubMed
description BACKGROUND: The effective detection and monitoring of potentially malignant oral lesions (PMOL) are critical to identifying early‐stage cancer and improving outcomes. In the current study, the authors described cytopathology tools, including machine learning algorithms, clinical algorithms, and test reports developed to assist pathologists and clinicians with PMOL evaluation. METHODS: Data were acquired from a multisite clinical validation study of 999 subjects with PMOLs and oral squamous cell carcinoma (OSCC) using a cytology‐on‐a‐chip approach. A machine learning model was trained to recognize and quantify the distributions of 4 cell phenotypes. A least absolute shrinkage and selection operator (lasso) logistic regression model was trained to distinguish PMOLs and cancer across a spectrum of histopathologic diagnoses ranging from benign, to increasing grades of oral epithelial dysplasia (OED), to OSCC using demographics, lesion characteristics, and cell phenotypes. Cytopathology software was developed to assist pathologists in reviewing brush cytology test results, including high‐content cell analyses, data visualization tools, and results reporting. RESULTS: Cell phenotypes were determined accurately through an automated cytological assay and machine learning approach (99.3% accuracy). Significant differences in cell phenotype distributions across diagnostic categories were found in 3 phenotypes (type 1 [“mature squamous”], type 2 [“small round”], and type 3 [“leukocytes”]). The clinical algorithms resulted in acceptable performance characteristics (area under the curve of 0.81 for benign vs mild dysplasia and 0.95 for benign vs malignancy). CONCLUSIONS: These new cytopathology tools represent a practical solution for rapid PMOL assessment, with the potential to facilitate screening and longitudinal monitoring in primary, secondary, and tertiary clinical care settings.
format Online
Article
Text
id pubmed-7078980
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-70789802020-03-19 Point‐of‐care oral cytology tool for the screening and assessment of potentially malignant oral lesions McRae, Michael P. Modak, Sayli S. Simmons, Glennon W. Trochesset, Denise A. Kerr, A. Ross Thornhill, Martin H. Redding, Spencer W. Vigneswaran, Nadarajah Kang, Stella K. Christodoulides, Nicolaos J. Murdoch, Craig Dietl, Steven J. Markham, Roger McDevitt, John T. Cancer Cytopathol Original Articles BACKGROUND: The effective detection and monitoring of potentially malignant oral lesions (PMOL) are critical to identifying early‐stage cancer and improving outcomes. In the current study, the authors described cytopathology tools, including machine learning algorithms, clinical algorithms, and test reports developed to assist pathologists and clinicians with PMOL evaluation. METHODS: Data were acquired from a multisite clinical validation study of 999 subjects with PMOLs and oral squamous cell carcinoma (OSCC) using a cytology‐on‐a‐chip approach. A machine learning model was trained to recognize and quantify the distributions of 4 cell phenotypes. A least absolute shrinkage and selection operator (lasso) logistic regression model was trained to distinguish PMOLs and cancer across a spectrum of histopathologic diagnoses ranging from benign, to increasing grades of oral epithelial dysplasia (OED), to OSCC using demographics, lesion characteristics, and cell phenotypes. Cytopathology software was developed to assist pathologists in reviewing brush cytology test results, including high‐content cell analyses, data visualization tools, and results reporting. RESULTS: Cell phenotypes were determined accurately through an automated cytological assay and machine learning approach (99.3% accuracy). Significant differences in cell phenotype distributions across diagnostic categories were found in 3 phenotypes (type 1 [“mature squamous”], type 2 [“small round”], and type 3 [“leukocytes”]). The clinical algorithms resulted in acceptable performance characteristics (area under the curve of 0.81 for benign vs mild dysplasia and 0.95 for benign vs malignancy). CONCLUSIONS: These new cytopathology tools represent a practical solution for rapid PMOL assessment, with the potential to facilitate screening and longitudinal monitoring in primary, secondary, and tertiary clinical care settings. John Wiley and Sons Inc. 2020-02-07 2020-03 /pmc/articles/PMC7078980/ /pubmed/32032477 http://dx.doi.org/10.1002/cncy.22236 Text en © 2020 The Authors. Cancer Cytopathology published by Wiley Periodicals, Inc. on behalf of American Cancer Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
McRae, Michael P.
Modak, Sayli S.
Simmons, Glennon W.
Trochesset, Denise A.
Kerr, A. Ross
Thornhill, Martin H.
Redding, Spencer W.
Vigneswaran, Nadarajah
Kang, Stella K.
Christodoulides, Nicolaos J.
Murdoch, Craig
Dietl, Steven J.
Markham, Roger
McDevitt, John T.
Point‐of‐care oral cytology tool for the screening and assessment of potentially malignant oral lesions
title Point‐of‐care oral cytology tool for the screening and assessment of potentially malignant oral lesions
title_full Point‐of‐care oral cytology tool for the screening and assessment of potentially malignant oral lesions
title_fullStr Point‐of‐care oral cytology tool for the screening and assessment of potentially malignant oral lesions
title_full_unstemmed Point‐of‐care oral cytology tool for the screening and assessment of potentially malignant oral lesions
title_short Point‐of‐care oral cytology tool for the screening and assessment of potentially malignant oral lesions
title_sort point‐of‐care oral cytology tool for the screening and assessment of potentially malignant oral lesions
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078980/
https://www.ncbi.nlm.nih.gov/pubmed/32032477
http://dx.doi.org/10.1002/cncy.22236
work_keys_str_mv AT mcraemichaelp pointofcareoralcytologytoolforthescreeningandassessmentofpotentiallymalignantorallesions
AT modaksaylis pointofcareoralcytologytoolforthescreeningandassessmentofpotentiallymalignantorallesions
AT simmonsglennonw pointofcareoralcytologytoolforthescreeningandassessmentofpotentiallymalignantorallesions
AT trochessetdenisea pointofcareoralcytologytoolforthescreeningandassessmentofpotentiallymalignantorallesions
AT kerraross pointofcareoralcytologytoolforthescreeningandassessmentofpotentiallymalignantorallesions
AT thornhillmartinh pointofcareoralcytologytoolforthescreeningandassessmentofpotentiallymalignantorallesions
AT reddingspencerw pointofcareoralcytologytoolforthescreeningandassessmentofpotentiallymalignantorallesions
AT vigneswarannadarajah pointofcareoralcytologytoolforthescreeningandassessmentofpotentiallymalignantorallesions
AT kangstellak pointofcareoralcytologytoolforthescreeningandassessmentofpotentiallymalignantorallesions
AT christodoulidesnicolaosj pointofcareoralcytologytoolforthescreeningandassessmentofpotentiallymalignantorallesions
AT murdochcraig pointofcareoralcytologytoolforthescreeningandassessmentofpotentiallymalignantorallesions
AT dietlstevenj pointofcareoralcytologytoolforthescreeningandassessmentofpotentiallymalignantorallesions
AT markhamroger pointofcareoralcytologytoolforthescreeningandassessmentofpotentiallymalignantorallesions
AT mcdevittjohnt pointofcareoralcytologytoolforthescreeningandassessmentofpotentiallymalignantorallesions